Results 91 to 100 of about 14,440 (242)

Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn’s disease with fecal calprotectin [PDF]

open access: yes, 2017
Background: Fecal biomarkers, especially fecal calprotectin, are useful for predicting endoscopic activity in Crohn’s disease; however, the cut-off point remains unclear. The aim of this paper was to analyze whether faecal calprotectin and M2 pyruvate
Machancoses, Francisco H.   +5 more
core   +1 more source

Five‐Year Outcomes and Disease Trajectories in Moderate‐to‐Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim The incidence of ulcerative colitis (UC) has been increasing in Asia. Comprehensive data on the long‐term course of moderate‐to‐severe UC remain scarce. This study investigated the clinical outcomes and factors associated with a disabling disease course in Korean patients with moderate‐to‐severe UC.
Byong Duk Ye   +14 more
wiley   +1 more source

Fecal Calgranulin C Versus Fecal Calprotectin as Non- Invasive Biomarkers in Predicting Activity and Severity of Ulcerative Colitis Compared to Colonoscopy [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease described by periods of relapse and remission. Monitoring disease activity typically requires invasive procedures like a colonoscopy.
Abdel-Wahab Mohammed Lotfy   +3 more
doaj   +1 more source

Periodontitis and Inflammatory Bowel Diseases: Mechanistic Evidence

open access: yesJournal of Periodontal Research, EarlyView.
This review aims to provide a conceptual framework for understanding the mechanistic interplay between periodontitis and IBD, with a particular emphasis on the microbial and immunological crosstalk linking the oral cavity and the gastrointestinal tract.
Ana Paula V. Colombo   +3 more
wiley   +1 more source

The effect of probiotics on fecal calprotectin in patients with cystic fibrosis

open access: yesThe Turkish Journal of Pediatrics, 2013
Cystic fibrosis (CF) is a common autosomal recessive disorder with different clinical manifestations, mainly in the gastrointestinal and respiratory tracts.
Gholamhossein Fallahi   +8 more
doaj  

Fecal Calprotectin Level in Neonates with Necrotizing Enterocolitis [PDF]

open access: yes, 2019
Background: Necrotizing enterocolitis (NEC) is a disease with high mortality. It is more present in premature infants and can also happen in term and late preterm neonates. It may affect any segment of the small intestine or colon. However, most commonly
Abdelmoneim Khashana   +2 more
core   +1 more source

Sustained Remission of Pediatric Bowel‐Associated Dermatosis‐Arthritis Syndrome With Risankizumab

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Bowel‐associated dermatosis‐arthritis syndrome (BADAS) is a rare neutrophilic dermatosis characterized by recurrent fever, arthralgias, and skin eruptions, most commonly occurring in patients with inflammatory bowel disease. We report the case of a 17‐year‐old female with Crohn's disease who developed BADAS and achieved complete and durable ...
Kylie E. Peake   +4 more
wiley   +1 more source

Fecal calprotectin concentrations in six age groups of healthy children. [PDF]

open access: yes, 2016
Fecal calprotectin concentrations in six age groups of healthy children.
Jinrong Liu (733835)   +6 more
core   +1 more source

Emotional Care, Emotionless Decisions

open access: yes
Acta Paediatrica, EarlyView.
Danilo Buonsenso
wiley   +1 more source

The role of neutrophils in the pathophysiology of inflammatory bowel diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) encompasses a spectrum of chronic disorders of the gastrointestinal tract, with a potential bidirectional relationship with periodontitis. Neutrophils are key regulators of immune‐inflammatory responses and play a major role in both diseases.
Joao Paulo Steffens   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy